Meet our Team

Stacey Bishop
LinkedIn

Stacey has been investing with Scale Venture Partners for over 15 years with a primary focus on Software as a Service and Digital Marketing. She currently serves on the Board of Directors of Aviso, Bizible, Demandbase, Extole, Lever and Sailthru and previously HubSpot (NYSE: HUBS) and Vitrue, prior to its acquisition by Oracle. Stacey also originated investments in ExactTarget, acquired by Salesforce in 2013 for $2.6B and Omniture, acquired by Adobe in 2009 for $1.8B.

Stacey is currently on the board of the Western Association of Venture Capitalist “WAVC” and an advisor to the University Venture Fund. Prior to Scale, Stacey specialized in M&A within Bank of America’s Corporate Development Group, worked in equity research at Morgan Stanley and began her career as an account manager at Syntel, an IT services firm.

Stacey holds an M.B.A. from Columbia Business School and a B.A. from University of Michigan.

Ray Bradford
LinkedIn

Ray Bradford is a partner at Kleiner Perkins Caufield & Byers. He joined the firm in 2011 and focuses on investments for the firm’s digital practice.
Before joining KPCB, Ray worked at Amazon Web Services and helped grow the company’s cloud infrastructure business. He led one of the core product management teams and was responsible for the definition, launch, and business growth of new database services, including Amazon Relational Database Services (RDS), Amazon ElastiCache, and Amazon DynamoDB. He is named inventor on multiple patent applications related to scalable data systems, and is excited by the opportunity for big data to drive efficiency gains and innovation in many sectors of the economy. Earlier in his career, Ray spent time at Twitter and Linden Lab (creators of the virtual world Second Life).

Ray earned his M.B.A. at Stanford University, where he was an Arjay Miller Scholar, and completed computer science coursework. Ray holds his B.S. degree in economics from Westminster College, where he graduated summa cum laude and served as student body president.

Jason Reading
LinkedIn

Prior to forming Aries Capital Partners with Rick Durham, Jason Reading was a partner at Peterson Partners. Jason invested in and sold numerous businesses in addition to serving on a variety of boards for portfolio companies. Prior to Peterson Partners, he held various positions at Leucadia National, a $10 billion publicly held investor in distressed assets. Jason also worked in the Technology Mergers and Acquisitions Group at Merrill Lynch and Audit and Business Advisory Services group at Price Waterhouse and is a licensed CPA and CMA. He holds an MBA from the Harvard Business School and a Bachelor’s Degree in accountancy from Brigham Young University. Jason was also a major in the Army National Guard and served a one-year tour of duty in Baghdad, Iraq where he served as a company commander for a combat engineer company.

Defina Toncheva
LinkedIn

A teenage emigrant from Bulgaria in 1998, Defina Toncheva arrived alone in the U.S. without guarantees, but with a relentless conviction to succeed. Leaving her homeland was “much more difficult than I expected because, like most of the entrepreneurs I meet, I was focused on the upside possibilities and was really not prepared for the difficulties I would inevitably encounter in a new place”. Yet, she parlayed her determination and talents into degrees at Harvard and Stanford, positions with leading corporations and a successful early career in technology investing.

Dafina joins USVP from Tugboat Ventures, where she was a principal investor since 2010. Prior to Tugboat, she spent two years at Venrock, where she helped expand the firm’s investments in the areas of SaaS, virtualization, security, infrastructure and enterprise applications. Her investments include Cloudflare and Aria Systems, both high flying leaders in next gen enterprise software. 

Before becoming a venture capitalist, Dafina held positions in development and product management at Microsoft, where she focused on authentication systems, digital signatures and business workflow. She worked on MSN Live ID and MS Office, and co-authored several key patents. Dafina has served as a Director at MATRIXX Software Inc. and Risk I/O, and as a board observer at PGP, Imperva, and Cloudflare. She earned a M.B.A. from Stanford Graduate School of Business and a B.S. in Computer Science, magna cum laude, with special focus on cryptography, efficient algorithms and database systems from Harvard University.

Peter Jarman
LinkedIn

Peter is a Managing Director for Cross Creek Advisors. He joined Cross Creek in 2010 after four years as a Senior Investment Manager for Fort Washington Capital Partners Group, where he assisted in managing its venture and private equity investment portfolios.

Prior to focusing on the investment side of private equity, Peter spent nearly 10 years operating in restructuring and marketing roles for venture and private equity funded companies. His experience includes senior roles at PTC, Ancestry.com, Campus Pipeline and Icon Health and Fitness. Peter received his MBA from the Northwestern Kellogg Graduate School of Management and was a finalist for the Ewing Kauffman Venture Fellows program.

Ben Dahl
LinkedIn

During his career, Ben has been a co-founder, COO & General Counsel of a startup, Unspam Technologies, where he co-created Project Honey Pot, a distributed honey pot network designed to identify, track and correlate spammers, email address harvesters and the like. He has also re-capped Echo Networks, a flagging dot-com, with strategic investments from massive music retailers to compete with the likes of iTunes. He also practiced law at Cooley LLP.

When he is away from the office, Ben enjoys his time with his wife and kids, traveling, skiing, cooking and eating great meals.

Lisa Dunlea
LinkedIn

Lisa has extensive experience in the medical device field and uses her expertise to benefit Signal Peak’s existing life science portfolio companies.

Lisa has over 17 years of operating and investment experience in the medical device industry. She was previously a principal at Oxford Bioscience Partners in Boston and prior to Oxford Bioscience, she was with Spray Venture Partners. Lisa was the COO of Deep Vein Medical, a co-founder of Pulmonary Therapeutics and an integral part of founding MyoScience. She has experience launching and marketing new products on a worldwide basis, leading R&D efforts, conducting clinical trials for PMA, and establishing quality assurance systems. She has held management positions at The Cleveland Clinic Foundation and World Medical, acquired by Medtronic, and positions of increasing responsibility at Cordis Endovascular Systems, acquired by Johnson & Johnson, and General Electric Medical Systems. Prior to the medical device industry she was an aerospace engineer at Pratt & Whitney.

Lisa was a Kauffman Fellow, has an M.S. degree in Mechanical Engineering from Florida International University and an M.B.A from The Wharton School of Business. She represents Signal Peak on the boards of Aspen Avionics, Athena Feminine Technologies, Coherex Medical, LineaGen, nanoMR, Numira Biosciences, and VeraLight.

Jeff Strong
LinkedIn

Jeff Strong is a retired consumer products executive, who is now working part time for the Marriott School to develop and launch the new Brand Management Lab. He previously held positions of global president and chief customer officer of Johnson & Johnson and executive vice president for Sun Products, the second largest North American manufacturer and marketer of fabric and dish cleaners and conditioners. He also held positions in customer development, marketing, and general management for Procter & Gamble during his twenty-one year career there. He earned his bachelor’s degree in business management from BYU and his MBA from the Kellogg School of Management at Northwestern University in Chicago. Jeff and Sara have five children and three grandchildren.

Jeremy Andrus
LinkedIn

Jeremy Andrus joined Traeger Wood Pellet Grills as President & CEO in January, 2014 and acquired the business alongside private equity fund Trilantic Capital Partners in July of that year. Prior to Traeger, he served as President and CEO of Skullcandy as well as on its board of directors. In eight years, Jeremy helped grow Skullcandy’s annual sales from less than $1 million to nearly $300 million. He served as Director of Strategic Planning and Acquisitions for boutique hotel owner and operator Kimpton Hotels & Restaurants Group from 2003 to 2005 and managed his own hotel development projects focused on Marriott franchise properties from 1998-2002. He served as a Consultant for Monitor Company from 1996 to 1998. Jeremy currently sits on the boards of directors for Wilson Electronics, PurePredictive and TrueGreece, and was formerly a board member of Goal Zero. He volunteers on the loan committee for refugee microfinance agency International Rescue Committee. Jeremy received his M.B.A. from Harvard Business School and B.A. from Brigham Young University. He lives in Salt Lake City with his wife and four daughters.

Myles Greenber
LinkedIn

Dr. Myles D. Greenberg, M.D. serves as Chief Development Officer of IntegraMed, Inc. Dr. Greenberg is a Partner at CHL Healthcare Partners, CHL Healthcare Partners, L.P. and CHL Medical Partners II, L.P. Dr. Greenberg joined CHL Healthcare Partners in 2004 and has led financings for 10 of its portfolio companies. He has led investments into a number of start-up and early-stage healthcare services and medical device companies.

Dr. Greenberg founded CareWell Urgent Care Centers of New England in 2012 and serves as its Lead Director. He has 25 years of experience in the medical device and healthcare sector and is active in the biotechnology, medical device and healthcare services sectors. Prior to joining CHL Medical Partners in 2004, Dr. Greenberg served as a Senior Principal and Vice President, Principal at Pappas Ventures, where he served on the Board of a number of companies and led six investments.

He is instrumental in recruiting top-notch management and setting business strategy as an active Director. He served as Vice President, Principal of A. M. Pappas Life Science Ventures II, L.P. and A.M. Pappas Life Science Ventures III, L.P. Prior to entering business school, Dr. Greenberg was an Assistant Clinical Director and Instructor of Emergency Medicine in the Department of Emergency Medicine at Beth Israel Deaconess Medical Center, Harvard Medical School, where he managed many of the clinical, educational, and administrative functions. He supervised patient care by a team of physicians, nurses, students, and other clinical staff and taught residents and medical students in a high volume, high acuity urban emergency department.

He received an M.D. from Yale University School of Medicine; an M.B.A. from Harvard Business School; and a B.A.S. from the University of Pennsylvania School of Engineering and Applied Science.